Jason A. Roberts
About
Jason A. Roberts is a scholar working on Pharmacology, Epidemiology and Molecular Medicine.
According to data from OpenAlex, Jason A. Roberts has authored 693 papers receiving a total of 28.0k indexed citations (citations by other indexed papers that have themselves been cited), including 474 papers in Pharmacology, 243 papers in Epidemiology and 178 papers in Molecular Medicine. Recurrent topics in Jason A. Roberts's work include Antibiotics Pharmacokinetics and Efficacy (470 papers), Antibiotic Resistance in Bacteria (178 papers) and Pneumonia and Respiratory Infections (143 papers). Jason A. Roberts is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (470 papers), Antibiotic Resistance in Bacteria (178 papers) and Pneumonia and Respiratory Infections (143 papers). Jason A. Roberts collaborates with scholars based in Australia, France and United States. Jason A. Roberts's co-authors include Jeffrey Lipman, Andrew Udy, David L. Paterson, Steven C. Wallis, Michael S. Roberts, Mohd H. Abdul‐Aziz, Fekade B. Sime, Brett McWhinney, Jacobus Ungerer and Jordi Rello and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Physical Review Letters.
In The Last Decade
Jason A. Roberts
664 papers receiving 27.3k citations
Hit Papers
Peers
Jason A. Roberts
Jeffrey Lipman Australia
David L. Paterson Australia
David P. Nicolau United States
Marin H. Kollef United States
George L. Drusano United States
Richard G. Wunderink United States
Keith S. Kaye United States
Matteo Bassetti Italy
Jordi Rello Spain
Sara E. Cosgrove United States
Citations per year, relative to Jason A. Roberts Jason A. Roberts (= 1×)
peers
Jeffrey Lipman
Countries citing papers authored by Jason A. Roberts
Since
Specialization
Citations
This map shows the geographic impact of Jason A. Roberts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason A. Roberts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason A. Roberts more than expected).
Fields of papers citing papers by Jason A. Roberts
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jason A. Roberts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason A. Roberts. The network helps show where Jason A. Roberts may publish in the future.
Co-authorship network of co-authors of Jason A. Roberts
This figure shows the co-authorship network connecting the top 25 collaborators of Jason A. Roberts. A scholar is included among the top collaborators of Jason A. Roberts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason A. Roberts. Jason A. Roberts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Heffernan, Aaron J., Xin Liu, Suzanne L. Parker, et al.. (2025). Ceftriaxone population pharmacokinetics in plasma and cerebrospinal fluid of neurocritical care patients. International Journal of Antimicrobial Agents. 65(5). 107461–107461.
2.
Roberts, Jason A., Luis Eduardo López-Cortés, James Pollard, et al.. (2025). Current practices in outpatient parenteral antimicrobial therapy programmes: an international multi-centre survey. JAC-Antimicrobial Resistance. 7(3). dlaf075–dlaf075.
3.
Roberts, Jason A., et al.. (2024). Outpatient parenteral antimicrobial therapy with carbapenems: A systematic review. Journal of Infection. 89(5). 106299–106299.
4.
Giuliano, Simone, et al.. (2024). Renal function and its impact on the concentration of ceftazidime-avibactam: A cross-sectional study. International Journal of Antimicrobial Agents. 64(6). 107351–107351.
5.
Novy, Emmanuel, Claire Roger, Jason A. Roberts, & Menino Osbert Cotta. (2023). Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis. Critical Care. 27(1). 449–449.
6.
Chai, Ming G., et al.. (2023). Beta-Lactam Dose Optimisation in the Intensive Care Unit: Targets, Therapeutic Drug Monitoring and Toxicity. Antibiotics. 12(5). 870–870.
7.
Tong, Steven Y. C., Justin T. Denholm, Gregory J. Dore, et al.. (2022). Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review. Clinical Pharmacokinetics. 61(10). 1331–1343.
8.
Coombes, Ian, Michael Dooley, Susan Poole, et al.. (2020). Physician drug prescribing preferences and availability for ventilation of patients with COVID-19. Critical Care and Resuscitation. 22(3). 271–274.
9.
Heffernan, Aaron J., Fekade B. Sime, Derek S. Sarovich, et al.. (2020). Pharmacodynamic Evaluation of Plasma and Epithelial Lining Fluid Exposures of Amikacin against Pseudomonas aeruginosa in a Dynamic In Vitro Hollow-Fiber Infection Model. Antimicrobial Agents and Chemotherapy. 64(9).
10.
Lipman, Jeffrey, Stephen J. Brett, Jan J. De Waele, et al.. (2019). A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III. Critical Care and Resuscitation. 21(1). 63–68.
11.
Tabah, Alexis, Matteo Bassetti, J.-R. Zahar, et al.. (2019). Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP). Intensive Care Medicine. 46(2). 245–265.
12.
Dhaese, Sofie, Pieter Colin, Jeffrey Lipman, et al.. (2018). Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models. Journal of Antimicrobial Chemotherapy. 74(2). 432–441.
13.
Kielstein, Jan T., David Czock, Jiao Xie, et al.. (2018). Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy. International Journal of Antimicrobial Agents. 52(2). 151–157.
14.
Tängdén, Thomas, Véronique Martin, Tim Felton, et al.. (2017). The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections. Intensive Care Medicine. 43(7). 1021–1032.
15.
Kalil, André C., Mark L. Metersky, Michael Klompas, et al.. (2016). Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clinical Infectious Diseases. 63(5). e61–e111.
16.
Jamal, Janattul‐Ain, Bruce A. Mueller, Gordon Choi, Jeffrey Lipman, & Jason A. Roberts. (2015). How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?. Diagnostic Microbiology and Infectious Disease. 82(1). 92–103.
17.
Dulhunty, Joel M., Jason A. Roberts, Joshua S. Davis, et al.. (2013). A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study. Critical Care and Resuscitation. 15(3). 179–185.
18.
McWhinney, Brett, et al.. (2013). The compatibility of a low concentration of hydrocortisone sodium succinate with selected drugs during a simulated Y-site administration. Critical Care and Resuscitation. 15(1). 63–66.
19.
Smith, Nicholas, et al.. (2012). Therapeutic drug monitoring when using cefepime in continuous renal replacement therapy: seizures associated with cefepime. Critical Care and Resuscitation. 14(4). 312–315.
20.
Dulhunty, Joel M., S. A. R. Webb, David L. Paterson, et al.. (2010). A survey of antibiotic prescribing practices in Australian and New Zealand intensive care units. Critical Care and Resuscitation. 12(3). 162–170.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jeffrey Lipman Breakdown of academic impact, for papers by David L. Paterson Breakdown of academic impact, for papers by David P. Nicolau Breakdown of academic impact, for papers by Marin H. Kollef Breakdown of academic impact, for papers by George L. Drusano Breakdown of academic impact, for papers by Richard G. Wunderink Breakdown of academic impact, for papers by Keith S. Kaye Breakdown of academic impact, for papers by Matteo Bassetti Breakdown of academic impact, for papers by Jordi Rello Breakdown of academic impact, for papers by Sara E. Cosgrove